PharmaShots Weekly Snapshot (April 20 -24, 2020)
1. Sanofi Receives the US FDAs Approval for its MenQuadfi Meningococcal (MenACWY) Conjugate Vaccine
Published: Apr 23, 2020 | Tags: Sanofi, Receives, US, FDA, Approval, MenQuadfi, Meningococcal, MenACWY, Conjugate Vaccine
2. ?? Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M
Published: Apr 24, 2020 | Tags: Takeda, Divest, Select OTC and Non-Core Assets, Orifarm, $670M
Published: Apr 24, 2020 | Tags: AstraZeneca, MSD, Report, Results, Lynparza, P-III, PROfound Study, BRCA1/2, ATM-Mutated, Metastatic, Castration-Resistant, Prostate Cancer
Published: Apr 23, 2020 | Tags: Merck & Co., Reports, Resubmission, sBLA, US, FDA, Keytruda, pembrolizumab, Six-Week, Dosing Schedule
Published: Apr 23, 2020 | Tags: Janssen, Collaborates, Emergent BioSolutions, Accelerate, Manufacturing, Vaccine, Against, COVID-19
Published: Apr 23, 2020 | Tags: Theravance, Reports, First Patient, Dosing, P-I Study, TD-0903, Treat, Patients, Acute Lung Injury, Associated, COVID-19
7. ? Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test in Finland
Published: Apr 22, 2020 | Tags: Mobidiag, Receives, Emergency Use Authorization, Automated, COVID-19 Test, Finland
8. LabCorp Receives the US FDAs Emergency Use Authorization for its COVID-19 At-Home Test Kit
Published: Apr 21, 2020 | Tags: LabCorp, Receives, US, FDA, Emergency Use Authorization, COVID-19, At-Home Test Kit
Published: Apr 23, 2020 | Tags: AstraZeneca, Signs, Clinical Trial Agreement, Saint Lukes Mid America Heart Institute, Initiate, P-III, DARE-19, Evaluating, Farxiga, Against, COVID-19
10. The European Commission Approves the Merger of Mylan and Upjohn with Conditions
Published: Apr 23, 2020 | Tags: European Commission, Approves, Merger, Mylan, Upjohn, Conditions
11. Valneva and Dynavax Collaborate to Advance the Development of Vaccine Against COVID-19
Published: Apr 22, 2020 | Tags: Valneva, Dynavax, Collaborate, Advance, Development, VLA 2001, Against, COVID-19
Published: Apr 22, 2020 | Tags: Sobi, Affiliate, Florio GmbH, Launches, Digital Platform, Improve, Lives, Patients, Hemophilia
13. Pfizer and BioNTech to Commence Clinical Study for COVID-19 in Germany
Published: Apr 22, 2020 | Tags: Pfizer, BioNTech, Commence, Clinical Study, COVID-19, Germany
14. Hope Biosciences Reports its Third US FDAs Approval for Clinical Trial in COVID-19
Published: Apr 22, 2020 | Tags: Hope Biosciences, Reports, Third, US, FDA, Approval, Clinical Trial, COVID-19
Published: Apr 22, 2020 | Tags: Novartis, Kymriah, tisagenlecleucel, Receives, US, FDA, Regenerative Medicine Advanced Therapy Designation, Follicular Lymphoma
16. Gilead and Kite Sign a Three Years Agreement with oNKo-innate to Discover Cancer Immunotherapies
Published: Apr 21, 2020 | Tags: Gilead, Kite, Sign, Three Years, Agreement, oNKo-innate, Discover, Cancer Immunotherapies
Published: Apr 21, 2020 | Tags: Bayer, Collaborates, Population Health Research Institute, Identify, Treatment, COVID-19
Published: Apr 21, 2020 | Tags: Novartis, Reports, Results, Mayzent, siponimod, P-III, EXPAND Study, Secondary Progressive Multiple Sclerosis
Published: Apr 21, 2020 | Tags: Sangamo, Signs, Exclusive, License Agreement, Mogrify, iPSC, ESC-Derived, Regulatory T-Cells
20. Noxopharm Anticipates the US FDAs Approval for Evaluating Veyonda in a Clinical Study for COVID-19
Published: Apr 21, 2020 | Tags: Noxopharm, Anticipates, US, FDA, Approval, Evaluating, Veyonda, Clinical Study, COVID-19
Published: Apr 21, 2020 | Tags: Roche, cobas HPV Test, Receives, US, FDA, Approval, cobas 6800/8800 System, Identify Women, Risk, Cervical Cancer
Published: Apr 20, 2020 | Tags: Cue Biopharma, Signs, Clinical Trial Collaboration, Merck, Evaluate, CUE-101, Keytruda, pembrolizumab, 1L, Treatment, HPV+, Recurrent/Metastatic, Head and Neck Cancer
Published: Apr 20, 2020 | Tags: RedHill Biopharma, Collaborates, NIAID, RHB-107, upamostat, WX-671, Against, COVID-19
Published: Apr 20, 2020 | Tags: Alexion, Initiate, P-III, Study, Ultomiris, ravulizumab-cwvz, Hospitalized Patients, Severe, COVID-19
Published: Apr 20, 2020 | Tags: Otsuka, Signs, Development, Commercialization, Agreement, Esperion, Nexletol, bempedoic acid, Nexlizet, bempedoic acid and ezetimibe, Japan
26. Fosun Pharma Receives the US FDAs EUA for its COVID-19 RT-PCR Detection Kit
Published: Apr 19, 2020 | Tags: Fosun Pharma, Receives, US, FDA, EUA, COVID-19 RT-PCR Detection Kit
Published: Apr 17, 2020 | Tags: Incyte, Initiates, P-III, RUXCOVID Study, Evaluating, Jakafi, ruxolitinib, Treat, Patients, COVID-19 Associated Cytokine Storm
28. Roche Reports the FDA and EMAs Acceptance of sBLA for Ocrevus Shorter 2-Hour Infusion Time
Published: Apr 20, 2020 | Tags: Roche, Reports, FDA, EMA, Acceptance, sBLA, Ocrevus, Shorter 2-Hour, Infusion Time
29. Novartis Signs an Agreement with the US FDA to Evaluate Hydroxychloroquine in Patients with COVID-19
Published: Apr 20, 2020 | Tags: Novartis, Signs, Agreement, US, FDA, Evaluate, Hydroxychloroquine, Patients, COVID-19
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com